Certified by Founder Lodge
Mass General Brigham Ventures
United States - Cambridge, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $105,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
-
Website
https://www.massgeneralbrigham.org/en/research-and-innovation/innovation/ventures
- Contact
- Social Links
Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new life science technologies emerging from Mass General Brigham’s vast research network. Our u
| Company | Date | Round | Raised |
|---|---|---|---|
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
 InStride Health |
April, 02 ,2024 | Series B | $30,000,000 |
 Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
 Affinia Therapeutics |
October, 10 ,2025 | Series C | $40,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
